Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin vs Carbetocin on Blood Loss During Laparoscopic Myomectomy
NCT05154279Recruiting
- Sponsor
- Wael Elbanna Clinic
- Start
- Feb 2022
- Primary completion
- Dec 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of terlipressin in Uterine Fibroids (UF) (3 arms), sponsored by Wael Elbanna Clinic. Primary endpoint: Blood loss at 12 hours. Started Feb 2022; status: recruiting.
02
Drugs
terlipressin
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT05154279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05154279.